Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
19.08%
Hard to borrow
ANTHERA PHARMS INC NEW
No one on the platform currently holds ANTH.
No tracked institution reports a position in ANTH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2017-05-01 | 1-for-8reverse |
| 2013-07-15 | 1-for-8reverse |
No one on the platform has traded ANTH yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$RDDT might have the strongest earnings and growth profile among companies under $35B market cap. Larry Ellison recently noted that AI is becoming commoditized, with most models trained on nearly identical datasets. Unique data is now a bottleneck, and Reddit’s 20 years of user conversations offer potential for monetization. Reddit has deals with $OPENAI.X and $GOOG and is also in a legal battle with $ANTH over unauthorized data scraping. If Reddit wins, Anthropic may start paying for access.
View on StockTwits ↗Figma is launching a new feature called “Code to Canvas” in partnership with Anthropic, enabling code generated by AI tools such as Claude Code to be converted into fully editable designs within Figma’s platform. The feature bridges AI coding tools and Figma’s design workflow, allowing users to transfer AI-built interfaces directly onto the canvas. Design teams can then refine layouts, compare variations, and collaborate more efficiently on final decisions. The partnership comes as Figma shares have fallen about 85% from their 52-week high of $142.92 reached in August, following the company’s IPO last summer. The stock has been caught in a broader selloff affecting many SaaS companies. Anthropic’s products have been central to what Wall Street traders have dubbed the “SAASpocalypse,” a sharp downturn in SaaS stocks. Figma is scheduled to report earnings Wednesday after the market close. $FIG $ANTH
View on StockTwits ↗$NVDA $ANTH https://wallstreetwaves.com/david-sacks-trumps-ai-czar-addresses-ai-chip-concerns-and-warns-of-over-regulations-risks-to-us-dom
View on StockTwits ↗$ANTH Running big on news. $EYPT huge run. $HA big run. $TCON Phase 3 update coming this month will move big.🦅🦅🦅🦅🦅🦅
View on StockTwits ↗@Cal1f0rn1aBay $ANTH looks to be trading about $.07 $SOS (Chinese crypto miner) $CLEU (Chinese edu stock) $BIO (license agreement recently) $ BLUE (short interest increase from 22.5M to about 24M and SI% increase from 36.3% to about 38-40%) $SPY
View on StockTwits ↗$ANTH what's the price on this? Otc dark defunct $SOS something big coming $CLEU merger with Aiways $BIO $BLUE
View on StockTwits ↗Anthera Pharmaceuticals ( $ANTH ) current valuation is… https://www.macroaxis.com/stock/ANTH/Anthera-Pharmaceuticals #stocks #news #wallstreet
View on StockTwits ↗$ANTH - Investment perspective on… https://www.macroaxis.com/competition/ANTH/BBIO/Anthera-vs-Bridgebio #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗Anthera Pharmaceuticals ( $ANTH ) current chance of distress is… https://www.macroaxis.com/stock/ANTH/Anthera-Pharmaceuticals #trading #ideas #stocks
View on StockTwits ↗$ANTH - The kurtosis is down to 66.0 as of today. https://www.macroaxis.com/invest/technicalIndicator/ANTH/Kurtosis
View on StockTwits ↗$ANTH Anthera Pharmaceuticals currently holds about 8.09 M in cash with (31.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
View on StockTwits ↗$ANTH always move with the volume. The volume is very slightly bullish. but it will take something like news merger or buy out to move it .
View on StockTwits ↗$ANTH volume moved in to this stock ??? All of a sudden??
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.